EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Virtual Control Groups in Non-clinical Toxicity Studies: Impacts on Toxicologic Clinical Pathology Data Interpretation

Adeyemi O Adedeji iD, Adi Wasserkrug Naor

Toxicologic Pathology · 2025

DOI: 10.1177/01926233241300310 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxicologic Pathology, 2025. Verfasst von Adeyemi O Adedeji und 1 weiteren Autor:innen. Beteiligte Einrichtung: Genentech Inc., South San Francisco, California, USA. Hauptthemen laut MEDLINE: Toxicity Tests, Control Groups, Pathology, Clinical, Toxicology. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the emerging concepts on the reduction of animal use in non-clinical studies is the use of virtual control group (VCG) to replace concurrent control group (CCG). The VCG involves the generation of a control data from historical control data to match a specific study design. This review focuses on two recently published proof-of-concept (POC) studies conducted in rats. One major issue that was consistently seen across these POC studies was the non-reproducibility of some quantitative endpoints between the CCG and the VCG, with clinical pathology parameters being the most affected. The inconsistencies observed with the clinical pathology parameters when using VCGs may lead to: (1) misconception about the accuracy and sensitivity of traditional clinical pathology biomarkers and its implications on safety monitoring in the clinic; (2) inability to correctly identify and characterize organ dysfunctions; (3) interference with the weight-of-evidence approach used in identifying hazards in toxicologic clinical pathology and toxicology studies at large; and (4) wrong interpretations and data reproducibility issues. Other alternatives to reduce animal use in toxicology studies are also discussed including blood microsampling for toxicokinetics, scientifically justified use of recovery animals, and appropriate use and continuous investments in new alternative methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toxicity TestsControl GroupsPathology, ClinicalToxicologyAnimalsRatsReproducibility of ResultsResearch Design

Stichwörter der Autor:innen

3Rsclinical pathologyconcurrent control grouptoxicologyvirtual control group

Autor:innen und Institutionen

  • Genentech Inc., South San Francisco, California, USA.
  • Johnson & Johnson, Spring House, Pennsylvania, USA.

ORCID-Profile: Adeyemi O Adedeji

Zitieren

APA

Adedeji, A. O., & Naor, A. W. (2025). Virtual Control Groups in Non-clinical Toxicity Studies: Impacts on Toxicologic Clinical Pathology Data Interpretation. Toxicologic Pathology. https://doi.org/10.1177/01926233241300310

Vancouver

Adedeji AO, Naor AW. Virtual Control Groups in Non-clinical Toxicity Studies: Impacts on Toxicologic Clinical Pathology Data Interpretation. Toxicologic Pathology. 2025. doi:10.1177/01926233241300310

BibTeX
@article{Adedeji2025,
  author = {Adedeji, Adeyemi O and Naor, Adi Wasserkrug},
  title = {Virtual Control Groups in Non-clinical Toxicity Studies: Impacts on Toxicologic Clinical Pathology Data Interpretation},
  journal = {Toxicologic Pathology},
  year = {2025},
  doi = {10.1177/01926233241300310}
}
Kostenlos starten →